Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...

CINCINNATI, Jan. 13, 2026 /PRNewswire/ -- In a groundbreaking proof-of-concept study, researchers at Cincinnati Children's report success at restoring healthy function to blood-making stem cells that ...

The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...

ANKTIVA® plus checkpoint inhibitor (CPI) therapy demonstrated statistically significant immune restoration across two ...

An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...

An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...

Monitoring ALC in the first 14 days post-cilta cel infusion may help identify patients with RRMM who are at high risk of developing neurocognitive TEAEs and cranial nerve palsy. Measuring certain ...

Background: Lung cancer remains the leading cause of cancer incidence and mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of cases, and the majority of ...

Research shows that incorporating absolute lymphocyte count into the SOFA score improves prognostic accuracy for patients with sepsis. “Unlike previous modifications of the SOFA score, this study ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced new paradigm changing findings from the Phase 2 QUILT-3.055 study, ...

1 Department of Infectious Diseases, Sixth People’s Hospital of Huizhou, Guangdong Province, Huizhou, China. 2 Department of Respiratory Medicine, Sixth People’s Hospital of Huizhou, Guangdong ...